John Adams to Glucagon-Like Peptide-1 Receptor
This is a "connection" page, showing publications John Adams has written about Glucagon-Like Peptide-1 Receptor.
Connection Strength
0.976
-
Cardiovascular and mortality benefits of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists as third-step glucose-lowering medicine in patients with type 2 diabetes: a retrospective cohort analysis. BMJ Open Diabetes Res Care. 2024 May 06; 12(3).
Score: 0.976